Results 271 to 280 of about 354,830 (305)
Some of the next articles are maybe not open access.
Project Inform perspective, 2002
There continues to be progress in the development of a number of new anti-HIV drugs. Additional research has focused on optimizing the use of protease inhibitors and non-nucleoside reverse transcriptase inhibitors (NNRTIs). This has resulted in studies of dual protease inhibitor combinations, protease inhibitor and NNRTI combinations and now dual NNRTI
openaire +1 more source
There continues to be progress in the development of a number of new anti-HIV drugs. Additional research has focused on optimizing the use of protease inhibitors and non-nucleoside reverse transcriptase inhibitors (NNRTIs). This has resulted in studies of dual protease inhibitor combinations, protease inhibitor and NNRTI combinations and now dual NNRTI
openaire +1 more source
Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection
Nature Reviews Drug Discovery, 2016Guido Ferrari +2 more
exaly
Project Inform perspective, 2002
Several studies of abacavir (Ziagen) were presented at the recent International Conference on AIDS in Durban. Most of the results are preliminary and are based only on interim analysis, but they do extend our knowledge of the use of the drug. They suggest that short-term use of a three-drug combination containing abacavir may be as effective as a three-
openaire +1 more source
Several studies of abacavir (Ziagen) were presented at the recent International Conference on AIDS in Durban. Most of the results are preliminary and are based only on interim analysis, but they do extend our knowledge of the use of the drug. They suggest that short-term use of a three-drug combination containing abacavir may be as effective as a three-
openaire +1 more source
5043422 Anti-HIV peptide and modified anti-HIV peptide
Biotechnology Advances, 1992openaire +1 more source
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption
New England Journal of Medicine, 2019Jana Blažková +2 more
exaly
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Nature, 2018Henning Gruell +2 more
exaly